Accelerated cell line development using two‐color fluorescence activated cell sorting to select highly expressing antibody‐producing clones
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The success of engineered monoclonal antibodies as biopharmaceuticals has generated considerable interest in strategies designed to accelerate development of antibody expressing cell lines. Stable mammalian cell lines that express therapeutic antibodies at high levels typically take 6–12 months to develop. Here we describe a novel method to accelerate selection of cells expressing recombinant proteins (e.g., antibodies) using multiparameter fluorescence activated cell sorting (FACS) in association with dual intracellular autofluorescent reporter proteins. The method is co‐factor‐independent and does not require complex sample preparation. Chinese hamster ovary (CHO) clones expressing high levels of recombinant antibody were selected on the basis of a two‐color FACS sorting strategy using heavy and light chain‐specific fluorescent reporter proteins. We were able to establish within 12 weeks of transfection cell lines with greater than a 38‐fold increase in antibody production when compared to the pool from which they were isolated, following a single round of FACS. The method provides a robust strategy to accelerate selection and characterization of clones and builds a foundation for a predictive model of specific productivity based upon on two‐color fluorescence. Biotechnol. Bioeng. 2008;99: 578–587. © 2007 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Production of recombinant protein therapeutics in cultivated mammalian cells
Wurm, F. M. (2004) · Nature Biotechnology · doi:10.1038/nbt1026 · Cited by 2,032 · cited 1×
“Mammalian cell lines such as Chinese hamster ovary (CHO) offer distinct advantages (reviewed in Wurm, 2004), including the ability to grow to high cell densities in serum-free media (Sinacore et al., 2000).”
BackgroundHendershot, L., Bole, D., Köhler, G., & Kearney, J. F. (1987) · The Journal of cell biology · doi:10.1083/jcb.104.3.761 · Cited by 340
Cited by
Cultivation strategies to enhance productivity of Pichia pastoris: A review
Looser, V., Bruhlmann, B., Bumbak, F., Stenger, C., Costa, M., Camattari, A., Fotiadis, D., & Kovar, K. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.05.008 · Cited by 350
“The most appropriate method of choice to screen for the ‘ best producer ’ in a population, fl uorescence activated cell sorting (FACS), enables the identi fi cation of satisfactory clones for several processes (Mattanovich and Borth, 2006; Sleiman et al., 2008).”
MethodGuidelines to cell engineering for monoclonal antibody production
Rita Costa, A., Elisa Rodrigues, M., Henriques, M., Azeredo, J., & Oliveira, R. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.10.002 · Cited by 178
“antibody-producing clones provides an attractive alternative to single-color immunocytochemical methods of detection [124].”
BackgroundInfluentialLuis Galbete, J., Buceta, M., & Mermod, N. (2008) · Molecular BioSystems · doi:10.1039/b813657b · Cited by 35
Metadata
- Authors
- Sleiman, R. J., Gray, P. P., McCall, M. N., Codamo, J., & Sunstrom, N. S.
- Venue
- Biotechnology and Bioengineering
- Publisher
- Wiley
- Published
- 2007-08-06
- Volume
- 99
- Issue
- 3
- Pages
- 578-587
- ISSN
- 0006-3592 (ISSN-L)
- 1097-0290
- OpenAlex
- W2128723663
- Cited by
- 70
- References
- 2
- FWCI
- 1.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Accelerated cell line development using two‐color fluorescence activated cell sorting to select highly expressing antibody‐producing clones. https://app.cochat.ai/papers/10.1002/bit.21612
- The paper
- Sleiman, R. J., Gray, P. P., McCall, M. N., Codamo, J., & Sunstrom, N. S. (2008). Accelerated cell line development using two‐color fluorescence activated cell sorting to select highly expressing antibody‐producing clones. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.21612
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.